CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

ATRA Quick Ratio for Trailing Twelve Months Period

(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
Y / Y Current Liabilities Growth 144.34 % 20.66 % 14.74 % -11.91 % -0.35 %
Y / Y Cash & cash equivalent Growth -35.04 % -27.95 % -26.3 % -24.66 % -20.22 %
Quick Ratio for Trailing Twelve Months Period 13.7 19.88 23.02 25.73 26.87
Total Ranking # 143 # 77 # 51 # 53 # 0
Seq. Current Liabilities Growth 43.13 % 43.86 % 47.1 % -19.33 % -29.32 %
Seq. Cash & cash equivalent Growth -17.12 % -7.68 % -5.96 % -9.72 % -8.08 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to jump in Current Liabilities in the IV. Quarter to $24 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 13.7 below Atara Biotherapeutics, Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 11 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 12
Sector # 38
S&P 500 # 143


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
35.85 26.85 12.84
(June 30. 2016)   (Dec 31 2017)


You need to upgrade your Flash Player



Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2017, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Adverum Biotechnologies, Inc.  35.96 
Krystal Biotech, Inc.  32.80 
Lion Biotechnologies, Inc.  29.96 
Kubota Pharmaceutical Holdings Co Ltd  29.74 
Gtx Inc  20.02 
Iovance Biotherapeutics, Inc.  16.76 
Crispr Therapeutics Ag  16.75 
Pulse Biosciences, Inc.  16.61 
Aclaris Therapeutics, Inc.  15.19 
Atara Biotherapeutics, Inc.  14.80 
Acceleron Pharma Inc  14.03 
Enzon Pharmaceuticals, Inc.  13.75 
Fennec Pharmaceuticals Inc.  12.88 
Aerie Pharmaceuticals Inc  12.68 
Organovo Holdings, Inc.  12.23 
Cadus Corp  11.84 
Novus Therapeutics, Inc.  11.80 
Microbot Medical Inc.  11.48 
Artemis Therapeutics, Inc.  11.37 
Idera Pharmaceuticals, Inc.  11.03 
Spark Therapeutics, Inc.  10.73 
Neurocrine Biosciences Inc  10.71 
Alder Biopharmaceuticals Inc  10.62 
Bluebird Bio, Inc.  10.51 
Edge Therapeutics, Inc.  10.19 
Voyager Therapeutics, Inc.  10.16 
G1 Therapeutics, Inc.  10.04 
La Jolla Pharmaceutical Co  9.94 
Obalon Therapeutics Inc  9.81 
Intellia Therapeutics, Inc.  9.70 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PDLB's Profile

Stock Price

PDLB's Financials

Business Description

Fundamentals

Charts & Quotes

PDLB's News

Suppliers

PDLB's Competitors

Customers & Markets

Economic Indicators

PDLB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071